Intramuscularly administered peptide A3-APO is effective against carbapenem-resistant Acinetobacter baumannii in mouse models of systemic infections

Multidrug-ResistantAcinetobacter baumanniiOutbreak in an Intensive Care Unit

(2014) G.B. Orsi et al.   JOURNAL OF CHEMOTHERAPY

The Antibacterial Effect of a Proline-Rich Antibacterial Peptide A3-APO

(2009) F. Rozgonyi et al.   CURRENT MEDICINAL CHEMISTRY

The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models

(2009) Dora Szabo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Induced Resistance to the Designer Proline-rich Antimicrobial Peptide A3-APO does not Involve Changes in the Intracellular Target DnaK

(2009) Marco Cassone et al.   International Journal of Peptide Research and Therapeutics

Infections in Combat Casualties During Operations Iraqi and Enduring Freedom

(2009) Clinton K. Murray et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

(2008) Paul Bart Noto et al.   PROTEIN SCIENCE